Linking Reduced Sensitivity to Peripheral Thyroid Hormones with CHD in T2DM

Overview

This study investigates the relationship between peripheral thyroid hormone sensitivity and coronary heart disease (CHD) in patients with type 2 diabetes mellitus (T2DM), highlighting the mediating role of serum albumin. Findings indicate that a decreased FT3/FT4 ratio is independently associated with CHD, with albumin accounting for a significant portion of this relationship.

Background

Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular mortality, particularly from coronary heart disease (CHD). Understanding the interplay between thyroid hormone sensitivity and cardiovascular health is crucial, as thyroid hormones influence various metabolic processes that can affect heart function. Identifying mediators like serum albumin may provide insights into potential therapeutic targets for reducing cardiovascular risk in this population.

Data Highlights

Key Findings

• The CHD group had significantly lower FT3/FT4 ratios compared to the non-CHD group.
• Albumin levels were also significantly reduced in the CHD group.
• A decreased FT3/FT4 ratio was independently associated with CHD risk.
• Albumin partially mediated the relationship between peripheral thyroid hormone sensitivity and CHD, accounting for 19.3% of the total effect.
• The FT3/FT4 ratio demonstrated a modest discriminative ability for CHD (AUC = 0.740).

Clinical Implications

Clinicians should consider assessing peripheral thyroid hormone sensitivity, particularly the FT3/FT4 ratio, in patients with T2DM to better evaluate cardiovascular risk. Monitoring serum albumin levels may also provide valuable insights into the cardiovascular health of these patients and guide management strategies.

Conclusion

Impaired peripheral thyroid hormone sensitivity is linked to an increased risk of CHD in patients with T2DM, with serum albumin serving as a potential mediator. These findings underscore the importance of evaluating thyroid function in the context of cardiovascular health in diabetic patients.

Related Resources & Content

1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Impact of Persistent Subclinical Hypothyroidism on Renal Complications in Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase II
2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Characterization of Gut Microbiome Profiles and Metabolites Linked to Albuminuria in Individuals with Type 2 Diabetes
3. Frontiers in Endocrinology, 2023 -- Nonlinear relationship between serum ferritin and diabetic retinopathy in patients with type 2 diabetes mellitus: mediating role of neutrophil-to-albumin ratio
4. Diabetes Care, 2026 -- Cardiovascular Disease and Risk Management: Standards of Care in Diabetes
5. Frontiers in Endocrinology — Atherogenic index of plasma and the severity of coronary artery stenosis in patients with type 2 diabetes mellitus: a retrospective cross-sectional study
6. Association between peripheral thyroid sensitivity and composite adverse outcome among inpatients with heart failure
7. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
8. Elevated neutrophil percentage-to-albumin ratio predicts increased all-cause and cardiovascular mortality among individuals with diabetes | Scientific Reports